The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress - elucidation by GADD34-deficient mice

被引:186
作者
Kojima, E
Takeuchi, A
Haneda, M
Yagi, F
Hasegawa, T
Yamaki, K
Takeda, K
Akira, S
Shimokata, K
Isobe, K
机构
[1] Natl Inst Longev Sci, Dept Basic Gerontol, Aichi 4748522, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Internal Med, Showa Ku, Aichi 4668520, Japan
[3] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 565, Japan
关键词
unfolded protein response; translational attenuation; eukaryotic initiation factor;
D O I
10.1096/fj.02-1184fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GADD34 is a protein that is induced by stresses such as DNA damage. The function of mammalian GADD34 has been proposed by in vitro transfection, but its function in vivo has not yet been elucidated. Here we generated and analyzed GADD34 knockout mice. Despite their embryonic stage- and tissue-specific expressions, GADD34 knockout mice showed no abnormalities at fetal development and in early adult life. However, in GADD34(-/-) mouse embryonic fibroblasts (MEFs), recovery from a shutoff of protein synthesis was delayed when MEFs were exposed to endoplasmic reticulum (ER) stress. The phosphorylation of eukaryotic translation initiator factor 2alpha (eIF2alpha) at Ser51 induced by thapsigargin or DTT was prolonged in GADD34(-/-) MEF, although following treatment with tunicamycin, the eIF2alpha phosphorylation level did not change in either GADD34(+/+) or GADD34(-/-) cells. ER stress stimuli induced expressions of Bip (binding Ig protein) and CHOP (C/EBP homologous protein) in MEF of wild-type mice. These expressions were strongly reduced in GADD34(-/-) MEF, which suggests that GADD34 up-regulates Bip and CHOP. These results indicate that GADD34 works as a sensor of ER stress stimuli and recovers cells from shutoff of protein synthesis.
引用
收藏
页码:1573 / +
页数:18
相关论文
共 36 条
[1]  
Adler HT, 1999, MOL CELL BIOL, V19, P7050
[2]   Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2α kinase [J].
Berlanga, JJ ;
Santoyo, J ;
de Haro, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (02) :754-762
[3]   The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34 [J].
Brown, SM ;
MacLean, AR ;
McKie, EA ;
Harland, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9442-9449
[4]   Heme-regulated eIF-2α kinase purifies as a hemoprotein [J].
Chefalo, PJ ;
Oh, JH ;
Rafie-Kolpin, M ;
Kan, B ;
Chen, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 258 (02) :820-830
[5]   In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation [J].
Chin, PL ;
Momand, J ;
Pfeifer, GP .
ONCOGENE, 1997, 15 (01) :87-99
[6]   HERPES-SIMPLEX VIRUS-1 GAMMA(1)34.5-GENE FUNCTION, WHICH BLOCKS THE HOST RESPONSE TO INFECTION, MAPS IN THE HOMOLOGOUS DOMAIN OF THE GENES EXPRESSED DURING GROWTH ARREST AND DNA-DAMAGE [J].
CHOU, J ;
ROIZMAN, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5247-5251
[7]   Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1 [J].
Connor, JH ;
Weiser, DC ;
Li, S ;
Hallenbeck, JM ;
Shenolikar, S .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) :6841-6850
[8]   DNA DAMAGE-INDUCIBLE TRANSCRIPTS IN MAMMALIAN-CELLS [J].
FORNACE, AJ ;
ALAMO, I ;
HOLLANDER, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :8800-8804
[9]   MAMMALIAN GENES COORDINATELY REGULATED BY GROWTH ARREST SIGNALS AND DNA-DAMAGING AGENTS [J].
FORNACE, AJ ;
NEBERT, DW ;
HOLLANDER, MC ;
LUETHY, JD ;
PAPATHANASIOU, M ;
FARGNOLI, J ;
HOLBROOK, NJ .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (10) :4196-4203
[10]   Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase [J].
Gale, M ;
Katze, MG .
PHARMACOLOGY & THERAPEUTICS, 1998, 78 (01) :29-46